FDA Announces Approval of Guidance Document for Continuous Marketing Applications Under Prescription Drug User Fee Act

Summary

The Food and Drug Administration (FDA) has received approval from the Office of Management and Budget (OMB) for a guidance document related to the Prescription Drug User Fee Act, which outlines the process for continuous marketing applications and scientific feedback during the development of fast-track products.